NIR178

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NIR178, covering 2024-03-01 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors [EARLY_Phase 1]